| Year | 2023 | 2022 |
|---|---|---|
| CF from Operating Activities | 1.41B | 1.4B |
| Net Income | 1.33B | 1.4B |
| Depreciation & Amortization | 352.42M | 350.29M |
| Deferred Income Taxes | 0 | 0 |
| Stock Based Compensation | 30.31M | 0 |
| Change in Working Capital | -262.53M | -3.41M |
| Accounts Receivable | 9.26M | -99.54M |
| Inventory | -238.34M | 7.55M |
| Accounts Payable | -39.41M | 60.28M |
| Other Working Capital | 5.96M | 28.3M |
| Other Non-Cash Items | -39.56M | -347.14M |
| CF from Investing Activities | 1.41B | 1.4B |
| Investments in Property, Plant & Equipment | -423.13M | -381.81M |
| Net Acquisitions | 0 | -65.46M |
| Investment Purchases | -304.3M | -2.68B |
| Sales/Maturities of Investments | 0 | 65.46M |
| Other Investing Activites | 80.94M | 81.74M |
| CF from Financing Activities | -507.06M | -257.98M |
| Debt Repayment | 120.55M | 23M |
| Common Stock Issued | 0 | 1.42M |
| Common Stock Repurchased | 0 | 0 |
| Dividends Paid | -567.12M | -125.42M |
| Other Financing Activites | -60.49M | -156.98M |
| Free Cash Flow | 940.56M | 1.02B |
| Operating Cash Flow | 1.41B | 1.4B |
| Capital Expenditures | -423.13M | -381.81M |
| Cash at Beginning of Period | 964.2M | 2.67B |
| Cash at End of Period | 1.14B | 964.2M |
| Net Change In Cash | 173.31M | -1.71B |
Advanced Enzyme Technologies Limited
ADVENZYMES.NS
NSE
276.45INR5.3 (0.33%)
ADVENZYMES.NS Financial Statements
Retained Earning Schedule
| Year | 2023 | 2022 |
|---|---|---|
| Retained Earnings (Previous Year) | 10.02B | 9.07B |
| Net Income | 1.33B | 1.06B |
| Stock Repurchases | 0 | 0 |
| Dividend Paid | -567.12M | -125.42M |
| Retained Earnings | 10.79B | 10.02B |
| Other Distributions | 205.02M | 824.38M |
PPE Schedule
| Year | 2023 | 2022 |
|---|---|---|
| Gross PPE | 3.07B | 2.89B |
| Annual Depreciation | 352.42M | 350.29M |
| Capital Expenditure | -423.13M | -381.81M |
| Net PPE | 3.14B | 2.92B |
Intangible and Goodwill Schedule
| Year | 2023 | 2022 |
|---|---|---|
| Acquisitions and Adjustments | 44.42M | 247.9M |
| Goodwill (Previous Year) | 3.21B | 2.96B |
| Goodwill | 3.25B | 3.21B |